Recap: HOOKIPA Pharma Q1 Earnings

HOOKIPA Pharma (NASDAQ:HOOK) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:01 AM. Here’s what…

HOOKIPA Pharma (NASDAQ:HOOK) reported its Q1 earnings results on Thursday, May 11, 2023 at 07:01 AM.

Here’s what investors need to know about the announcement.

Earnings

HOOKIPA Pharma missed estimated earnings by 17.39%, reporting an EPS of $-0.27 versus an estimate of $-0.23.

Revenue was up $1.73 million from the same period last year.

Past Earnings Performance

Last quarter the company beat on EPS by $0.04 which was followed by a 2.44% increase in the share price the next day.

Here’s a look at HOOKIPA Pharma’s past performance:

Quarter Q4 2022 Q3 2022 Q2 2022 Q1 2022
EPS Estimate -0.21 -0.28 -0.36 -0.24
EPS Actual -0.17 -0.25 -0.23 -0.40
Revenue Estimate 7.07M 2.91M 3.56M 14.53M
Revenue Actual 7.83M 2.23M 2.75M 1.45M

To track all earnings releases for HOOKIPA Pharma visit their earnings calendar here.

This article was generated by Benzinga’s automated content engine and reviewed by an editor.

Total
0
Shares
Related Posts
Read More

Bank of America’s Q4 Revenue Dips 10%; CFO Highlights Organic Growth, 4.6M Credit Card Accounts Addition

Bank of America Corp (NYSE: BAC) reported an adjusted net income of $5.9 billion for the fourth quarter of FY23, with an adjusted EPS of $0.70, surpassing the consensus estimate of $0.68. The bank's revenue, net of interest expense, showed a year-over-year decrease of 10% to $22.0 billion, while the adjusted revenue fell by 4% to $23.5 billion, slightly missing the consensus of $23.7 billion.

BAC